EirGenix Inc. (TWSE: 6589)
Health Care · Life Sciences Tools & Services · TW
NT$51.30
+0.98% today · -29.1% 1Y
EirGenix Inc. (TWSE: 6589) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $479.15M and employs 1,000 people.
Over the last twelve months the share price has lost 29.1%, trading between 40.15 and 84.30.
Tweenvest scores EirGenix Inc. across four factors: quality 66/100, value 70/100. Its strongest factor is value.
6589 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $479.15M
- Revenue (TTM)
- $38.14M
- P/E
- —
- EPS
- -1.88
- Dividend yield
- —
- Beta (5Y)
- 0.31
- 52-week high
- NT$84.30
- 52-week low
- NT$40.15
- Avg volume (3M)
- —
- Shares outstanding
- 298.65M
- Employees
- 1,000
- Next earnings
- —
About EirGenix Inc.
EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatment of cancer and currently under biologics license application status; EG1206A, a Pertuzumab biosimilar, indicated for the treatment of cancer and currently under Phase I stage; EG13074, indicated for the treatment of cancer and currently under Preclinical stage; TSY0110(EG12043), an antibody-drug conjugate, indicated for the treatment of cancer and currently under Preclinical stage; EG12021, Bevacizumab biosimilar, indicated for the treatment of cancer and currently under Preclinical stage; and EG62054, a biosimilar, currently under Preclinical stage. In addition, the company manufactures and sells covid-19 antigen rapid test; and EG74032, a CRM197 carrier protein. The company was incorporated in 2012 and is headquartered in New Taipei City, Taiwan.
- ISIN
- TW0006589005
- Founded
- 2012
- Listed since
- Nov 23, 2016
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Curiox Biosystems Co., LtdKOSDAQ: A445680 | $684.61M | ₩53,500.00 | -8.08% |
| Innova Captab LimitedNSEI: INNOVACAP | $656.33M | Rs1,110.00 | -4.97% |
| Evotec SEXTRA: EVT | $550.90M | €2.46 | -11.13% |
| Jiangsu Hanbon Science and Technology Co., Ltd.SHSE: 688755 | $493.26M | CN¥28.88 | -4.50% |
| SMO ClinPlus CO.,LTD.SZSE: 301257 | $475.34M | CN¥40.30 | -5.64% |
| Alpha Teknova, Inc.NasdaqGM: TKNO | $474.60M | $8.53 | -3.51% |
| Viva Biotech HoldingsSEHK: 1873 | $408.85M | HK$1.55 | +1.31% |
| Zhejiang Tailin BioEngineering Co.,LtdSZSE: 300813 | $403.22M | CN¥22.51 | -1.40% |
Figures last refreshed Oct 11, 2026.